Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.
about
Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionAdenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarctionVasodilators in the treatment of patients with acute myocardial infarction undergoing percutaneous coronary interventionCoronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and managementShort-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trialsT2-weighted imaging to assess post-infarct myocardium at risk.Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRICardiac purinergic signalling in health and diseaseThe REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised cEfficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-AnalysisClinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled trials.Management of 'no-reflow' complicating reperfusion therapy.The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary interventionEfficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting.Prevention and treatment of no-reflow.New strategies for the management of no-reflow after primary percutaneous coronary intervention.No-reflow phenomenon: maintaining vascular integrity.The management of thrombotic lesions in the cardiac catheterization laboratory.Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?Developing drugs for use before, during and soon after percutaneous coronary intervention.The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.
P2860
Q24187926-3A243D7A-2FE2-4293-9BD4-6C9AA5F817F0Q24202298-A19CD30F-D39D-43EA-B9B4-C7C854637CC8Q24234883-DC908AEE-39FE-4DE8-ADB6-0AF897E160EBQ26830317-419C7917-4BC7-425A-A9A4-E1940C1122F7Q27013629-5916D8A9-0EB0-44BF-B648-7C06E4519A1AQ30425254-634536EF-0E20-404B-AC51-59CC957DAEB6Q30435260-62DB37E5-2A4A-4C38-8E61-14E7C2377479Q30437694-9AE02850-A0F5-4536-A5B8-C571656E355AQ33165093-47497B51-91F7-4A63-BA49-AD8EEAA047F1Q34305843-8B4D55E5-180E-4BFC-B0BC-7A3D78279B05Q36195096-2CDF8FEF-3D87-492C-AB23-672E746068EEQ36345758-AAC36129-C724-4652-96C2-49D313D43B82Q37152013-1D068CA9-A1C1-4C42-95F6-154DF9F5C07DQ37431525-CBACCA30-7D58-45CE-86D8-EBCB98D242E0Q37708215-0E41C23E-81D4-4FB5-B6F7-E30A9EC6F277Q37779094-FCA58DB0-C6FB-4F2B-A3CF-BE89EF04E6DAQ37880139-3FB83A3F-3DE0-46BF-B012-8322B4473105Q37912834-9EC1E9B1-86E5-4C48-8A25-48109B4414F8Q37947959-8CF66A63-2D1B-4DD8-8C6A-6AE35CAD2F5AQ38543451-A970601E-4119-4493-B074-635B1CC34B12Q38708145-117A4DA5-26E2-4E6E-8F67-5CA79A56C502Q42830474-BDF3A28B-A400-4500-A423-B87BCFEFD308
P2860
Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Improvement in microvascular r ...... ing primary coronary stenting.
@ast
Improvement in microvascular r ...... ing primary coronary stenting.
@en
type
label
Improvement in microvascular r ...... ing primary coronary stenting.
@ast
Improvement in microvascular r ...... ing primary coronary stenting.
@en
prefLabel
Improvement in microvascular r ...... ing primary coronary stenting.
@ast
Improvement in microvascular r ...... ing primary coronary stenting.
@en
P2093
P1476
Improvement in microvascular r ...... ing primary coronary stenting.
@en
P2093
Antonio Micari
Eduardo A Balcells
Eric Powers
Jonathan R Lindner
Sanjiv Kaul
Todd A Belcik
P304
P356
10.1016/J.AMJCARD.2005.06.090
P407
P577
2005-09-27T00:00:00Z